Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

E I Du Pont De Nemours And Co (DD), The Dow Chemical Company (DOW): Should We Follow Nelson Peltz Into This Stock

Since the beginning of the year, E I Du Pont De Nemours And Co (NYSE:DD) has experienced a nice gain of as much as 33%, beating the S&P 500’s gain of nearly 20%. Recently, famous activist investor Nelson Peltz revealed at the Delivering Alpha conference that he has purchased a lot of the company’s shares. Let’s take a closer look to determine whether or not we should follow Nelson Peltz into DuPont now.

A cash cow and a strong balance sheet with decent dividend yield

E I Du Pont De Nemours And Co (NYSE:DD) has a long operating history dated back to 1802, operating in eight reportable business segments, including Agriculture, Electronics & Communications, Industrial Biosciences, Nutrition & Health, Performance Chemicals, Performance Materials, Safety & Protection, and Pharmaceuticals. It employs around 70,000 people with operations in more than 90 countries globally. Agriculture and Performance Chemicals are the two biggest profit contributors, with around $1.59 billion in operating income in 2012. The third place belongs to the Performance Materials business, with more than $1 billion in operating income.

E I Du Pont De Nemours And CoWhat I like about E I Du Pont De Nemours And Co (NYSE:DD) is its cash generation capability. In the past ten years, DuPont has managed to generate consistent positive cash flow. The operating cash flow increased from $2.59 billion in 2003 to nearly $4.85 billion in 2012 while free cash flow grew from $876 million to more than $3 billion during the same period. Moreover, DuPont employs some leverage in its operations. As of June 2013, it had nearly $13.3 billion in equity, nearly $6.9 billion in cash, and around $7.2 billion in net debt.

E I Du Pont De Nemours And Co (NYSE:DD) has generated higher shareholder returns via business restructuring. First, it redesigned its cost structure to deliver around $2 billion in total savings over the past four years. Second was portfolio enhancement, including a $7 billion acquisition of Danisco and the $5 billion sale of performance coatings to The Carlyle Group. In terms of long-term performance, DuPont expects to grow its sales by around 7% and operating EPS by around 12%.

Higher valuation than Dow Chemical and BASF

The market values E I Du Pont De Nemours And Co (NYSE:DD) at around 10.6 times its trailing EBITDA (earnings before interest, taxes, depreciation, and amortization). The dividend yield is decent at 3.10%. Compared to its peers The Dow Chemical Company (NYSE:DOW) and BASF SE (ADR) (OTCMKTS:BASFY), DuPont is the most expensive among the three.

The market values The Dow Chemical Company (NYSE:DOW) at 7.86 times its trailing EBITDA. Recently, Dow Chemical witnessed earnings growth and margin expansion. In the second quarter of 2013, Dow Chemical experienced better operating performance. Its adjusted EPS came in at $0.64, nearly 16.4% higher than the EPS of $0.55 in the second quarter last year. Adjusted EBITDA grew 8.7% year-over-year to $2.13 billion.

The higher earnings and improvement in margins in the second quarter was due to the company’s restructuring program, the growing Performance Plastics business, especially in North America on strong shale fundamentals, and higher equity earnings. Looking forward, The Dow Chemical Company (NYSE:DOW) expects to benefit from improvement in the U.S. market, driven by residential construction.

The company stays bullish about fundamentals in key end markets, including high farm incomes, transportation market growth, and improvement in the electronics industry. Thus, The Dow Chemical Company (NYSE:DOW), with its global leading position, could be a good stock in the long run. Income investors might also like Dow Chemical due to its juicy dividend yield of 3.70%.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.